| 6.315 -0.025 (-0.39%) | 12-05 10:01 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | ||||
| Targets | 6-month : | 8.65 | 1-year : | 9.88 |
| Resists | First : | 7.4 | Second : | 8.46 |
| Pivot price | 6 |
|||
| Supports | First : | 5.71 | Second : | 4.75 |
| MAs | MA(5) : | 6.13 |
MA(20) : | 6.08 |
| MA(100) : | 7.85 |
MA(250) : | 0 | |
| MACD | MACD : | -0.4 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 88.7 |
D(3) : | 65.2 |
| RSI | RSI(14): 41.5 |
|||
| 52-week | High : | 9.61 | Low : | 4.94 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SIGA ] has closed below upper band by 4.2%. Bollinger Bands are 59.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 6.36 - 6.38 | 6.38 - 6.41 |
| Low: | 6.08 - 6.11 | 6.11 - 6.14 |
| Close: | 6.29 - 6.34 | 6.34 - 6.38 |
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Tue, 02 Dec 2025
Understanding the Setup: (SIGA) and Scalable Risk - news.stocktradersdaily.com
Mon, 01 Dec 2025
Siga Technologies: As Market Waits For MPOXX Purchases, I Remain On The Sidelines - Seeking Alpha
Sun, 30 Nov 2025
SIGA Technologies Inc (NASDAQ:SIGA) Nasdaq Composite Public-Health Solutions - Kalkine Media
Sun, 16 Nov 2025
Siga Technologies Inc. $SIGA Shares Sold by Aviva PLC - MarketBeat
Fri, 14 Nov 2025
Siga Technologies Inc. $SIGA Shares Sold by Los Angeles Capital Management LLC - MarketBeat
Fri, 14 Nov 2025
Take Care Before Jumping Onto SIGA Technologies, Inc. (NASDAQ:SIGA) Even Though It's 26% Cheaper - simplywall.st
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 72 (M) |
| Shares Float | 41 (M) |
| Held by Insiders | 43.2 (%) |
| Held by Institutions | 49.4 (%) |
| Shares Short | 3,120 (K) |
| Shares Short P.Month | 2,740 (K) |
| EPS | 1.02 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.83 |
| Profit Margin | 43.2 % |
| Operating Margin | -390.2 % |
| Return on Assets (ttm) | 26.4 % |
| Return on Equity (ttm) | 39.9 % |
| Qtrly Rev. Growth | -73.9 % |
| Gross Profit (p.s.) | 1.57 |
| Sales Per Share | 2.4 |
| EBITDA (p.s.) | 1.26 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 117 (M) |
| Levered Free Cash Flow | 88 (M) |
| PE Ratio | 6.11 |
| PEG Ratio | 0 |
| Price to Book value | 2.21 |
| Price to Sales | 2.61 |
| Price to Cash Flow | 3.86 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 9.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |